Cargando…

Fecal Microbiota Transplantation is a Promising Switch Therapy for Patients with Prior Failure of Infliximab in Crohn’s Disease

Background: How to handle patients with anti-tumor necrosis factor (anti-TNF) failure was a common challenge to clinicians in Crohn’s disease (CD). The present study is dedicated to clarifying whether fecal microbiota transplantation (FMT) could be a switch therapy for patients with prior failure of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qianqian, Ding, Xiao, Liu, Yujie, Marcella, Cicilia, Dai, Min, Zhang, Ting, Bai, Jianling, Xiang, Liyuan, Wen, Quan, Cui, Bota, Zhang, Faming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166050/ https://www.ncbi.nlm.nih.gov/pubmed/34079458 http://dx.doi.org/10.3389/fphar.2021.658087

Ejemplares similares

Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes
por: Li, Qianqian, et al.
Publicado: (2020)

Rapamycin is Effective for Upper but not for Lower Gastrointestinal Crohn’s Disease-Related Stricture: A Pilot Study
por: Zhong, Min, et al.
Publicado: (2021)

Washed microbiota transplantation improves the fertility of patients with inflammatory bowel disease
por: Zhao, Zhaoyang, et al.
Publicado: (2022)

The Safety of Fecal Microbiota Transplantation for Crohn’s Disease: Findings from A Long-Term Study
por: Wang, Honggang, et al.
Publicado: (2018)

Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening
por: Zhang, Ting, et al.
Publicado: (2020)

Efficacy of faecal microbiota transplantation in Crohn’s disease: a new target treatment?
por: Xiang, Liyuan, et al.
Publicado: (2020)

Distinct alterations of fecal microbiota refer to the efficacy of adalimumab in Crohn’s disease
por: Chen, Liang, et al.
Publicado: (2022)

Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn’s disease
por: Li, Pan, et al.
Publicado: (2018)

Exclusive Enteral Nutrition Plus Immediate vs. Delayed Washed Microbiota Transplantation in Crohn's Disease With Malnutrition: A Randomized Pilot Study
por: Xiang, Liyuan, et al.
Publicado: (2021)

The bowel preparation for magnetic resonance enterography in patients with Crohn’s disease: study protocol for a randomized controlled trial
por: Dai, Min, et al.
Publicado: (2019)

The impact of medication belief on adherence to infliximab in patients with Crohn’s disease
por: Li, Shuyan, et al.
Publicado: (2023)

A novel role of the splenic volume in Crohn’s disease: evaluating the efficacy of infliximab
por: Shi, Xuan, et al.
Publicado: (2023)

The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation
por: He, Ruiqiao, et al.
Publicado: (2022)

Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn’s disease complicated with inflammatory mass
por: He, Zhi, et al.
Publicado: (2017)

Improvement of Good’s syndrome by fecal microbiota transplantation: the first case report
por: Jagessar, Sabreen Abdul Rahman, et al.
Publicado: (2019)

Cost-effectiveness analysis of fecal microbiota transplantation for inflammatory bowel disease
por: Zhang, Ting, et al.
Publicado: (2017)

Clinical and Immunological Factors Associated with Recommended Trough Levels of Adalimumab and Infliximab in Patients with Crohn’s Disease
por: Orts, Beatriz, et al.
Publicado: (2022)

Development and Validation of an Interleukin-6 Nomogram to Predict Primary Non-response to Infliximab in Crohn’s Disease Patients
por: Chen, Yueying, et al.
Publicado: (2021)

The recognition and attitudes of postgraduate medical students toward fecal microbiota transplantation: a questionnaire study
por: Wu, Xia, et al.
Publicado: (2019)

Washed microbiota transplantation stopped the deterioration of amyotrophic lateral sclerosis: The first case report and narrative review
por: Lu, Gaochen, et al.
Publicado: (2023)

The Underlying Changes in Serum Metabolic Profiles and Efficacy Prediction in Patients with Extensive Ulcerative Colitis Undergoing Fecal Microbiota Transplantation
por: Wu, Xia, et al.
Publicado: (2023)

How Chinese clinicians face ethical and social challenges in fecal microbiota transplantation: a questionnaire study
por: Ma, Yonghui, et al.
Publicado: (2017)

Association between genetic variants and development of antibodies to infliximab: A cross-sectional study in Chinese patients with Crohn’s disease
por: Zhu, Kouzhu, et al.
Publicado: (2023)

Step-up fecal microbiota transplantation (FMT) strategy
por: Cui, Bota, et al.
Publicado: (2016)

Fecal microbiota transplantation for refractory Crohn's disease
por: Bak, Seon Ho, et al.
Publicado: (2017)

Clinical efficacy maintains patients’ positive attitudes toward fecal microbiota transplantation
por: Xu, Lijuan, et al.
Publicado: (2016)

Infliximab in the treatment of Crohn’s disease
por: Poggioli, Gilberto, et al.
Publicado: (2007)

Fecal microbiota transplantation results in bacterial strain displacement in patients with inflammatory bowel diseases
por: Zou, Manli, et al.
Publicado: (2019)

Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update
por: Tan, Pufang, et al.
Publicado: (2020)

Changes in the Intestinal Microbiota Are Seen Following Treatment with Infliximab in Children with Crohn’s Disease
por: Kowalska-Duplaga, Kinga, et al.
Publicado: (2020)

Awareness and attitude of fecal microbiota transplantation through transendoscopic enteral tubing among inflammatory bowel disease patients
por: Zhong, Min, et al.
Publicado: (2020)

A Cost-Utility Analysis of Switching from Reference to Biosimilar Infliximab Compared to Maintaining Reference Infliximab in Adult Patients with Crohn’s Disease
por: Hughes, Avery, et al.
Publicado: (2020)

Colonic transendoscopic enteral tubing: A novel way of transplanting fecal microbiota
por: Peng, Zhaoyuan, et al.
Publicado: (2016)

Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism
por: Xiao, Fangfei, et al.
Publicado: (2022)

Short-Term Surveillance of Cytokines and C-Reactive Protein Cannot Predict Efficacy of Fecal Microbiota Transplantation for Ulcerative Colitis
por: Zhang, Ting, et al.
Publicado: (2016)

Instant messaging client gives the opportunity to recognize gut microbiota and dysbiosis-related disease: An investigation study on WeChat APP
por: Liu, Yujie, et al.
Publicado: (2022)

Infliximab to treat Crohn’s disease: an update
por: Cottone, M, et al.
Publicado: (2011)

Fecal MicroRNAs Show Promise as Noninvasive Crohn’s Disease Biomarkers
por: Wohnhaas, Christian T, et al.
Publicado: (2020)

Ginsenoside Rc ameliorated atherosclerosis via regulating gut microbiota and fecal metabolites
por: Xie, Bin, et al.
Publicado: (2022)

Efficacy and safety of fecal microbiota transplantation for the treatment of irritable bowel syndrome: an overview of overlapping systematic reviews
por: Zhang, Di, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jqio5qk4nbqm2f18to1jugbs0r